Filing Details
- Accession Number:
- 0001209191-19-031450
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-20 17:08:20
- Reporting Period:
- 2019-05-16
- Accepted Time:
- 2019-05-20 17:08:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1697532 | Applied Therapeutics Inc. | APLT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1216955 | S Joel Marcus | C/O Applied Therapeutics, Inc. 340 Madison Avenue, 19Th Floor New York NY 10173 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-16 | 110,497 | $0.00 | 119,668 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 135,192 | $0.00 | 254,860 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 150,000 | $10.00 | 404,860 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2019-05-16 | 110,497 | $0.00 | 110,497 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2019-05-16 | 135,192 | $0.00 | 135,192 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019.
Billionaire Hedge Funds
